#crispr-technology

[ follow ]
www.bbc.com
1 month ago
OMG science

First gene-editing therapy may cure blood disorder

The NHS will offer gene-editing therapy for beta thalassaemia, potentially curing the blood disorder without the need for lifelong blood transfusions. [ more ]
time.com
4 months ago
OMG science

Stuart Orkin

Dr. Stuart Orkin's research on identifying genes regulating fetal hemoglobin led to a revolutionary gene therapy for sickle cell disease using CRISPR technology. [ more ]
#Crispr technology
WIRED
9 months ago
Medicine

The First Crispr Medicine Is Now Approved in the US

Casgevy uses Crispr technology to modify patients' cells and produce healthy hemoglobin.
Casgevy has shown promising results in a clinical trial, with 29 out of 31 patients being free of pain crises for at least a year. [ more ]
WSJ
9 months ago
Medicine

FDA Approves World's First Crispr Gene-Editing Drug for Sickle-Cell Disease

The US has approved the world's first medicine using Crispr technology.
Crispr technology has the potential to treat genetic conditions that are difficult to treat. [ more ]
WIRED
9 months ago
Medicine

The First Crispr Medicine Is Now Approved in the US

Casgevy uses Crispr technology to modify patients' cells and produce healthy hemoglobin.
Casgevy has shown promising results in a clinical trial, with 29 out of 31 patients being free of pain crises for at least a year. [ more ]
WSJ
9 months ago
Medicine

FDA Approves World's First Crispr Gene-Editing Drug for Sickle-Cell Disease

The US has approved the world's first medicine using Crispr technology.
Crispr technology has the potential to treat genetic conditions that are difficult to treat. [ more ]
moreCrispr technology
MedCity News
10 months ago
Medicine

U.K. Is First to Approve a CRISPR-Based Therapy, Covering Two Blood Disorders

The UK has authorized a gene-editing medicine for treating sickle cell disease and beta thalassemia, marking the first approval worldwide for a therapy based on CRISPR technology.
The therapy, known as Casgevy, involves editing a gene in a patient's stem cells to produce high levels of fetal hemoglobin.
Casgevy offers a potentially curative treatment option for these inherited blood disorders, reducing the need for chronic therapies and blood transfusions. [ more ]
www.scientificamerican.com
3 months ago
OMG science

Easy-to-Use CRISPR Tests Could Change How We Diagnose COVID and Other Illnesses

CRISPR-based tests can detect pathogens with PCR-level sensitivity without requiring preamplification. [ more ]
[ Load more ]